ArticleBrain sciences2025
Hybrid Deep Learning Architecture with Adaptive Feature Fusion for Multi-Stage Alzheimer's Disease Classification.
Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence with deep learning driven entropy-curvature attention mechanism for detection and segmentation of skin lesions using biomedical images.Scientific reports · 2026Article
- Harnessing attention-driven hybrid deep learning with combined feature representation for precise sign language recognition to aid deaf and speech-impaired people.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND/
objectivesAlzheimer's disease (AD), a progressive neurodegenerative disorder, demands precise early diagnosis to enable timely interventions. Traditional convolutional neural networks (CNNs) and deep learning models often fail to effectively integrate localized brain changes with global connectivity patterns, limiting their efficacy in Alzheimer's disease (AD) classification.
methodsThis research proposes a novel deep learning framework for multi-stage Alzheimer's disease (AD) classification using T1-weighted MRI scans. The adaptive feature fusion layer, a pivotal advancement, facilitates the dynamic integration of features extracted from a ResNet50-based CNN and a vision transformer (ViT). Unlike static fusion methods, our adaptive feature fusion layer employs an attention mechanism to dynamically integrate ResNet50's localized structural features and vision transformer (ViT) global connectivity patterns, significantly enhancing stage-specific Alzheimer's disease classification accuracy.
resultsEvaluated on the Alzheimer's 5-Class (AD5C) dataset comprising 2380 MRI scans, the framework achieves an accuracy of 99.42% (precision: 99.55%; recall: 99.46%; F1-score: 99.50%), surpassing the prior benchmark of 98.24% by 1.18%. Ablation studies underscore the essential role of adaptive feature fusion in minimizing misclassifications, while external validation on a four-class dataset confirms robust generalizability.
conclusionsThis framework enables precise early Alzheimer's disease (AD) diagnosis by integrating multi-scale neuroimaging features, empowering clinicians to optimize patient care through timely and targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.